Yoshinari Tanabe

Yoshinari Tanabe

Auto-generated profile, based on publicly available information

Yoshinari Tanabe

Niigata Prefectural Shibata Hospital, Niigata, Japan

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SASeitaro Abe
Seitaro Abe
YTYoshinari Tanabe
Yoshinari Tanabe
TOTakeshi Ota
Takeshi Ota
FFFumio Fujimori
Fumio Fujimori
AYAkira Youkou
Akira Youkou
MMMasato Makino
Masato Makino
Background: Nocardiosis is known as an opportunistic infection in immunocompromised hosts, but it occasionally has been reported in immunocompetent patient. The Nocardia exalbida is first-reported in 2006 from Japan, and a few cases of have been reported in only immunocompromised host, and the characteristic is still unclear. We herein describe the first case of pulmonary nocardiosis caused by N. exalbida in an immunocompetent patient. Case presentation: A77 -year-old Japanese man was admitted to our hospital on November 2, 2018. He was a lifelong non-smoker with no childhood history of respiratory disease. He had a medical history of dyslipidemia. One month before this admission fevers, sputum, mild cough were developed and he was evaluated in a clinic near our hospital. His diagnosis was community acquired pneumonia within his right middle lobe. He was treated with ceftriaxone 1 g/day intravenously for a week, however his symptoms relapsed a few days later. So, the physician retried ceftriaxone for another 3 days, but his symptoms did not improve. He was referred to our hospital. He was treated with sitafloxacin as an outpatient for a week, however his symptoms got worse. The chest CT showed consolidation and atelectasis in his right middle lobe. Low density area was scattered in consolidation, and right pleural effusion was observed. The patient was diagnosed with pulmonary abscess and he was admitted. Administration of piperacillin/tazobactam improved his condition. We switched antibiotics to amoxicillin/clavulanate, and he was discharged. After 2 weeks, he relapsed and was admitted again. After administration of piperacillin/tazobactam for 3 weeks, we perform bronchoscopy and Nocardia species were cultured from samples of the bronchial wash. The isolates were identified as N. exalbida using 16S rRNA gene sequencing. We prescribed Trimethoprim / Sulfamethoxazole (TMP/SMX) for 4 months. Then we switched to minocycline for renal dysfunction caused from TMP-SMX for 1 more month. After 5 months therapy, Consolidation on CT disappeared, and Nocardiosis was cured. Conclusion: we reported the first case of pulmonary nocardiosis caused by N. exalbida in an immunocompetent patient. N. exalbida infection might be associated with a good response to treatment.

27 April 2022 in Vaccine
Verified
Journal Article
Closed access
KTKosuke Tamura
Kosuke Tamura
BCBin Chang
Bin Chang
RSReiko Shimbashi
Reiko Shimbashi
HWHiroshi Watanabe
Hiroshi Watanabe
YTYoshinari Tanabe
Yoshinari Tanabe
KOKazunori Oishi
Kazunori Oishi

1 January 2003 in Kansenshogaku Zasshi
Verified
Journal Article
Open access
HMHiroshi Moro
Hiroshi Moro
HTHiroki Tsukada
Hiroki Tsukada
TOTatsuki Ohara
Tatsuki Ohara
RSRitsuko Susa
Ritsuko Susa
YTYoshinari Tanabe
Yoshinari Tanabe
FGFumitake Gejyo
Fumitake Gejyo
Using Amebocyte lysate of horseshoe crab to measure (1-->3)-beta-D-glucan specifically, a component of the cell wall, several kinds of diagnostic methods for deep mycosis are in practical use in Japan. However, the most important problem is that the judgment of positive or negative is method dependent. To elucidate the cause of the problem, each measurement value of the identical sample by four methods, beta-Glucan Test Maruha (MARUHA), beta-Glucan Test Wako (WAKO). FUNGITEC G Test (FUNGITEC-G) and FUNGITEC G Test MK (FUNGITEC-MK) was compared with the clinical data using 119 cases and 289 tests. Each case was divided into three groups; proven fungal infection, probable fungal infection and non-fungal infection. The negative cases for all the methods tested in the groups of proven fungal infection and probable fungal infection were allergic bronchopulmonary aspergillosis and cryptococcosis, and that for all the methods tested except FUNGITEC-MK method in the group was pulmonary aspergilloma. It seems that these cases cannot be detected correctly by only measuring (1-->3)-beta-D-glucan. On the other hand, the ratio of false positive, positive for non-fungal infection group was high in the case of FUNGITEC-MK. About 23% against the total case was positive for FUNGITEC-MK method, but negative for MARUHA, WAKO, and FUNGITEC-G methods. Although the difference of the sensitivity among four methods was not observed, the specificity, the diagnostic efficiency, and the positive predictive value of FUNGITEC-MK method were remarkably lower than those of the other methods due to false positive measurement. In conclusion, MARUHA, WAKO and FUNGITEC-G except FUNGITEC-MK is not method dependent. It is suggested that FUNGITEC-MK detects non-specific reaction resulted in false positive.

5 April 2024 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
KTKosuke Tamura
Kosuke Tamura
RSReiko Shimbashi
Reiko Shimbashi
AKAyu Kasamatsu
Ayu Kasamatsu
BCBin Chang
Bin Chang
KGKenji Gotoh
Kenji Gotoh
KOKazunori Oishi
Kazunori Oishi
We aimed to investigate the impact of preceding seasonal influenza on the clinical characteristics of adult patients with invasive pneumococcal disease (IPD) in Japan. Data for 1,722 adult patients with IPD were analyzed before (2017-2019) and during the COVID-19 pandemic (2020-2022). Seasonal influenza epidemic disappeared soon after the emergence of the pandemic. Compared with that before the pandemic (66.7%), we observed a lower bacteremic pneumonia proportion in patients with IPD during the pandemic (55.6%). The clinical presentations of IPD cases significantly differed between those with and without preceding influenza. The proportion of bacteremic pneumonia was higher in IPD patients with preceding influenza than in those without in both younger (44.9% vs. 84.2%) and older adults (65.5% vs. 87.0%) before the pandemic. The case fatality rate was significantly higher in IPD patients with preceding influenza (28.3%) than in those without (15.3%) in older adults before the pandemic (P = 0.020). Male and aging are high risk factors for death in older patients with IPD who had preceding influenza. Our study reveals that preceding seasonal influenza plays a role in the development of bacteremic pneumococcal pneumonia, increasing the risk of death in older adults.

1 January 2014 in Allergology International
Verified
Journal Article
Open access
NKNao Koshio
Nao Koshio
NGNiigata Asthma Treatment Study Group
Niigata Asthma Treatment Study Group
THTakashi Hasegawa
Takashi Hasegawa
KSKazuo Suzuki
Kazuo Suzuki
YTYoshinari Tanabe
Yoshinari Tanabe
ESEiichi Suzuki
Eiichi Suzuki
Influenza infection is known to be an exacerbating factor in the control of asthma, therfore its prevention is critical in managing asthma. The aim of this study was to investigate the influenza A H1N1 2009 pandemic virus (H1N1 pdm09) infection in adult asthmatic patients. Data were obtained from a questionnaire-based survey of asthmatic patients conducted from September to October 2010 in Niigata Prefecture. Patient background, H1N1 pdm09 infection, vaccination status, and asthma exacerbation due to influenza infection were analyzed. In total, 2,555 cases were analyzed. The incidence of the infection was 6.7% (95% confidence interval [CI]: 5.7-7.6), and the rate of vaccination was 63.9% (95% CI: 62.1-65.8). The odds ratio (OR) for vaccination against the infection among adult patients and younger patients (≤ the median age) were 0.61 (95% CI: 0.45-0.84) and 0.62 (95% CI: 0.42-0.90), respectively. However, OR among the older patient (> median age) were 1.38 (95%CI: 0.66-2.89). The rate of infection-induced asthma exacerbation was 23.2% (95% CI: 18.6-29.6), and the OR for vaccination against the infection-induced asthma exacerbation was 1.42 (95% CI: 0.69-2.92). The effectiveness of the vaccination against the H1N1 pdm09 virus was confirmed during the first pandemic season, but it was limited. Further investigation on H1N1 pdm09 virus infection in asthmatics will be required.

25 May 2019 in Japanese Journal of Infection Prevention and Control
Verified
Journal Article
Open access
PDF file
MSMizuho Sato
Mizuho Sato
MUMasako Uchiyama
Masako Uchiyama
MAMieko Aoki
Mieko Aoki
ASAkiko Sakagami
Akiko Sakagami
CTChikako Tsubata
Chikako Tsubata
TKToshiaki Kikuchi
Toshiaki Kikuchi
2013年に新定義のVentilator-Associated Events(VAE)サーベイランスが提唱されたが我が国における報告は限られている.我々は2013年12月1日から2016年3月31日に新潟大学医歯学総合病院のIntensive Care Unit(ICU)で人工呼吸器を使用した18歳以上の患者に対しVAEサーベイランスと旧定義Ventilator-Associated Pneumonia(VAP)サーベイランスを行い比較検討した.対象患者290例中Ventilator-Associated Conditions(VAC)14例,Infection-related Ventilator-Associated Complications(IVAC)7例,Possible VAP(PVAP)8例,旧定義VAP7例(発生率3.6,1.8,2.1,1.8/1000人工呼吸器使用日数)であった.非VAE非VAP例に比し,人工呼吸器使用日数・ICU滞在日数はPVAP例と旧定義VAP例で,総死亡率・ICU死亡率はVAC例とPVAP例で有意に高かった.旧定義VAP7例中VAEとの一致は4例で不一致の主な要因は酸素化の悪化が軽度でVAEの定義を満たさなかったことであった.VAEサーベイランスは旧定義VAP同定に対する感度は低いが我が国においても予後予測の面で有用である可能性がある.